Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2021-12-23 Governance Information
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
年度信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is titled as a "重大差错责任追究制度" which translates to "Major Error Responsibility Accountability System" related to the annual report information disclosure. It details the company's internal rules and procedures for handling significant errors in annual report disclosures, including definitions, standards for identifying major errors, responsibility assignment, and procedures for accountability. It references laws, regulations, and company governance documents, and it was approved by the board on December 24, 2021. The document does not contain actual financial statements or financial data but rather outlines governance and compliance procedures related to annual report disclosures. Therefore, it is a governance-related document detailing internal rules and practices rather than the annual report itself or an announcement of a report. It fits best under Governance Information (CGR). The document length is 4539 characters, which is not extremely short, and it is not a mere announcement or certification. Hence, the classification is CGR with high confidence.
2021-12-23 Chinese
董事会议事规则
Governance Information Classification · 95% confidence The document is titled '董事会制度' (Board of Directors System) and contains detailed rules and procedures governing the board of directors of the company 四川梓橦宫药业股份有限公司. It includes sections on board composition, duties, meeting procedures, voting, and decision-making authority. There is no financial data, earnings information, or report publication announcement. The content is focused on governance structure and internal rules of the board. Therefore, it fits the category of Governance Information (CGR). The document length (7944 characters) and detailed content support this classification with high confidence.
2021-12-23 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled '股东大会制度' which translates to 'Shareholders Meeting System' or 'Shareholders Meeting Rules'. It details the rules and procedures for convening and conducting shareholders meetings, including voting rights, proposal submissions, meeting notices, and other governance-related procedures. It references legal and regulatory frameworks and the company's articles of association. There is no financial data, earnings information, or audit content. It is a governance document outlining internal rules for shareholder meetings rather than an announcement or report of a specific meeting or vote. Therefore, it fits best under Governance Information (CGR). The document length (6991 characters) and content confirm it is a full governance report, not a brief announcement or notice.
2021-12-23 Chinese
公司章程
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board structure, share issuance, capital, shareholder meetings, and governance rules. It is a legal and governance document that outlines the internal rules and structure of the company rather than a financial report, announcement, or meeting material. There is no indication that this is an annual report, earnings release, proxy statement, or any other financial or regulatory filing. The content fits the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2021-12-23 Chinese
关于召开公司2022年第一次临时股东大会的通知公告
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 first extraordinary general meeting of shareholders (临时股东大会) for Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items for shareholder approval, and procedural information. It does not contain financial statements or results but is an announcement related to a shareholder meeting. The content aligns with a formal meeting notice rather than the meeting materials or voting results. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2021-12-23 Chinese
第三届监事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the seventh meeting of the third Supervisory Board of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, and voting results related to amendments to the company's articles of association and supervisory board rules. There is no financial data, earnings information, or report publication mentioned. The content focuses on board-level decisions and governance matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management.
2021-12-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.